Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 16,858 |
|
|||||
| News | - | ||||||
| Day High | 1.31 | Low High |
|||||
| Day Low | 1.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclo Therapeutics Inc | CYTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -0.77% | 1.29 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.26 | 1.26 | 1.31 | 1.29 | 1.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 106 | 16,858 | $ 1.29 | $ 21,799 | - | 0.6801 - 2.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:13:17 | 20 | $ 1.36 | USD |
Cyclo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 29.32M | 22.73M | - | 1.08M | -20.06M | -0.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cyclo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.32 | 1.10 | 1.22 | 45,046 | 0.09 | 7.50% |
| 1 Month | 1.38 | 1.79 | 1.10 | 1.39 | 105,129 | -0.09 | -6.52% |
| 3 Months | 1.90 | 1.92 | 1.10 | 1.54 | 96,836 | -0.61 | -32.11% |
| 6 Months | 1.01 | 2.115 | 0.8924 | 1.56 | 101,935 | 0.28 | 27.72% |
| 1 Year | 0.8336 | 2.57 | 0.6801 | 1.51 | 97,818 | 0.4564 | 54.75% |
| 3 Years | 7.12 | 13.00 | 0.67 | 4.37 | 101,506 | -5.83 | -81.88% |
| 5 Years | 4.35 | 17.75 | 0.67 | 6.38 | 228,325 | -3.06 | -70.34% |
Cyclo Therapeutics Description
| Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. |
